RW Investment Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,318
Closed -$268K 116
2026
Q1
$268K Buy
+7,318
New +$289K 0.03% 96
2025
Q3
$325K Sell
7,683
-147
-2% -$5.54K 0.03% 80
2025
Q2
$244K Buy
+7,830
New +$212K 0.03% 94
2025
Q1
Sell
-8,547
Closed -$244K 99
2024
Q4
$244K Hold
8,547
0.03% 86
2024
Q3
$228K Hold
8,547
0.03% 89
2024
Q2
$219K Buy
+8,547
New +$192K 0.03% 85
2023
Q4
Sell
-11,970
Closed -$181K 83
2023
Q3
$181K Sell
11,970
-2,656
-18% -$43K 0.03% 81
2023
Q2
$251K Sell
14,626
-4,293
-23% -$63.2K 0.05% 75
2023
Q1
$248K Sell
18,919
-485
-2% -$6.2K 0.07% 75
2022
Q4
$235K Buy
+19,404
New +$233K 0.09% 73

Other funds holding AORT

RW Investment Management's AORT Position: Q2 2026 in Review

RW Investment Management sold out of Artivion (AORT) in Q2 2026, closing a stake of 7,318 shares — an estimated $268K sold.

RW Investment Management first reported a position in AORT in Q4 2022 and held it in 10 quarters. The position peaked at $325K in Q3 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • RW Investment Management reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • RW Investment Management sold 7,318 Artivion shares in Q2 2026, an estimated $268K.
  • RW Investment Management first reported a position in Artivion in Q4 2022 and held it in 10 quarters.
  • RW Investment Management's Artivion position peaked at $325K in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on RW Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.